| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |